Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone loss

Menopause

Volumn 20, Issue 6, 2013, Pages 677-686

  Turner, Russell T ^a   Iwaniec, Urszula T ^a   Andrade, Juan E ^b   Branscum, Adam J ^a   Neese, Steven L ^b   Olson, Dawn A ^a   Wagner, Lindsay ^a   Wang, Victor C ^b   Schantz, Susan L ^b   Helferich, William G ^b  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Micro CT; Osteoporosis; Phytoestrogen; Rat bone; Soy isoflavone

Indexed keywords

GENISTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BONE DENSITY; BONE MASS; CONTROLLED STUDY; DIAPHYSIS; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; MASS; METAPHYSIS; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; POSTMENOPAUSE; RAT; THERAPY EFFECT; TIBIA; TRABECULAR BONE; TREATMENT DURATION;

AGING; ANIMALS; BONE DENSITY; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; GENISTEIN; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PHYTOESTROGENS; RATS; RATS, LONG-EVANS; REPRODUCTION; TIBIA;

EID: 84879188929     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e31827d44df     Document Type: Article

References (69)

1. Schlaman HRM, Phillips DA, Kondorosi E. Genetic Organization and Transcriptional Regulation of Rhizobial Nodulation Genes. In: Spaink HP, Kondorosi A, Hooykaas PJJ, eds. The Rhizobiaceae: Molecular Biology of Model Plant-associated Bacteria Dordrecht, the Netherlands: Kluwer Academic Publishers, 1998:361-386.
2. Lang K, Lindemann A, Hauser F, Gottfert M. The genistein stimulon of Bradyrhizobium japonicum. Mol Genet Genomics 2008;279:203-211.
3. Gyorgypal Z, Kondorosi A. Homology of the ligand-binding regions of Rhizobium symbiotic regulatory protein NodD and vertebrate nuclear receptors. Mol Gen Genet 1991;226:337-340.
4. Dang ZC. Dose-dependent effects of soy phyto-oestrogen genistein on adipocytes: Mechanisms of action. Obes Rev 2009;10:342-349.
5. Bektic J, Guggenberger R, Eder IE, et al. Molecular effects of the isoflavonoid genistein in prostate cancer. Clin Prostate Cancer 2005;4: 124-129.
6. Fox JE. Chemical communication threatened by endocrine-disrupting chemicals. Environ Health Perspect 2004;112:648-653.
7. Jefferson WN, Padilla-Banks E, Newbold RR. Studies of the effects of neonatal exposure to genistein on the developing female reproductive system. J AOAC Int 2006;89:1189-1196.
8. Oberdorster E, Clay MA, Cottam DM, Wilmot FA, McLachlan JA, Milner MJ. Common phytochemicals are ecdysteroid agonists and antagonists: A possible evolutionary link between vertebrate and invertebrate steroid hormones. J Steroid Biochem Mol Biol 2001;77:229-238.
9. Rogers J. Estrogens in the menopause and postmenopause. N Engl J Med 1969;280:364-367.
10. Turner RT, Rickard DJ, Iwaniec UI, Spelsberg TC. Estrogens and progestins. In: Bilezikian JP, Raisz LG, Martin J, eds. Principles of Bone Biology, New York: Academic Press, 2008:847-877.
11. Iwaniec UI, Turner RT. Animal models of osteoporosis. In: Marcus R, Feldman D, Nelson DA, Rosen C, eds. Osteoporosis. Amsterdam, the Netherlands: Elsevier, 2008:985-1110.
12. Neese SL, Wang VC, Doerge DR, et al. Impact of dietary genistein and aging on executive function in rats. Neurotoxicol Teratol 2010;32: 200-211.
13. Iwaniec UT, Wronski TJ, Turner RT. Histological analysis of bone. Methods Mol Biol 2008;447:325-341.
14. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987;2:595-610.
15. Thomsen JS, Laib A, Koller B, Prohaska S, Mosekilde L, Gowin W. Stereological measures of trabecular bone structure: Comparison of 3D micro computed tomography with 2D histological sections in human proximal tibial bone biopsies. J Microsc 2005;218:171-179.
16. Team RDC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, http://www.R-project.org, 2010.
17. Watanabe S, Yamaguchi M, Sobue T, et al. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 1998;128:1710-1715.
18. Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 1995;125:2307-2315.
19. Evans GL, Turner RT. Tissue-selective actions of estrogen analogs. Bone 1995;17:181S-190S.
20. Moon LY, Wakley GK, Turner RT. Dose-dependent effects of tamoxifen on long bones in growing rats: Influence of ovarian status. Endocrinology 1991;129:1568-1574.
21. Westerlind KC, Wronski TJ, Ritman EL, et al. Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain. Proc Natl Acad Sci U S A 1997;94: 4199-4204.
22. Hung AJ, Stanbury MG, Shanabrough M, Horvath TL, Garcia-Segura LM, Naftolin F. Estrogen, synaptic plasticity and hypothalamic reproductive aging. Exp Gerontol 2003;38:53-59.
23. Miller SC, Anderson BL, Bowman BM. Weaning initiates a rapid and powerful anabolic phase in the rat maternal skeleton. Biol Reprod 2005; 73:156-162.
24. Miller SC, Bowman BM. Comparison of bone loss during normal lactation with estrogen deficiency osteopenia and immobilization osteopenia in the rat. Anat Rec 1998;251:265-274.
25. Sibonga JD, Zhang M, Ritman EL, Turner RT. Restoration of bone mass in the severely osteopenic senescent rat. J Gerontol A Biol Sci Med Sci 2000;55:B71-B78; discussion, B79-B84.
26. Chen WF, Wong MS. Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells. Br J Nutr 2006;95: 1039-1047.
27. Gao YH, Yamaguchi M. Zinc enhancement of genistein's anabolic effect on bone components in elderly female rats. Gen Pharmacol 1998;31: 199-202.
28. Yamaguchi M. Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. Yakugaku Zasshi 2006;126: 1117-1137.
29. Yamaguchi M, Weitzmann MN. The estrogen 17A-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-JB activity. Int J Mol Med 2009;23:297-301.
30. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor A. Endocrinology 1998;139:4252-4263.
31. Mueller SO, Simon S, Chae K, Metzler M, Korach KS. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor > (ER>) and ERA in human cells. Toxicol Sci 2004;80:14-25.
32. Henley DV, Korach KS. Endocrine-disrupting chemicals use distinct mechanisms of action to modulate endocrine system function. Endocrinology 2006;147:S25-S32.
33. Turner RT, Kidder LS, Zhang M, et al. Estrogen has rapid tissue-specific effects on rat bone. J Appl Physiol 1999;86:1950-1958.
34. Bouker KB, Hilakivi-Clarke L. Genistein: Does it prevent or promote breast cancer? Environ Health Perspect 2000;108:701-708.
35. Hilakivi-Clarke L, Cho E, Onojafe I, Raygada M, Clarke R. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep 1999;6: 1089-1095.
36. Hilakivi-Clarke L, Onojafe I, Raygada M, et al. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer 1999;80:1682-1688.
37. Murata M, Midorikawa K, Koh M, Umezawa K, Kawanishi S. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogensensitive organs. Biochemistry 2004;43:2569-2577.
38. Newbold RR, Banks EP, Bullock B, Jefferson WN. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 2001;61: 4325-4328.
39. Marini H, Bitto A, Altavilla D, et al. Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: A follow-up study. J Clin Endocrinol Metab 2008;93:4787-4796.
40. Newton KM, LaCroix AZ, Levy L, et al. Soy protein and bone mineral density in older men and women: A randomized trial. Maturitas 2006; 55:270-277.
41. Weaver CM, Martin BR, Jackson GS, et al. Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology. J Clin Endocrinol Metab 2009;94:3798-3805.
42. Ricci E, Cipriani S, Chiaffarino F, Malvezzi M, Parazzini F. Soy isoflavones and bone mineral density in perimenopausal and postmenopausal Western women: A systematic review and meta-analysis of randomized controlled trials. J Womens Health (Larchmt) 2010;19: 1609-1617.
43. Levis S, Strickman-Stein N, Ganjei-Azar P, Xu P, Doerge DR, Krischer J. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: A randomized, double-blind trial. Arch Intern Med 2011;171:1363-1369.
44. Newton KM, Grady D. Soy isoflavones for prevention of menopausal bone loss and vasomotor symptoms: Comment on Bsoy isoflavones in the prevention of menopausal bone loss and menopausal symptoms[. Arch Intern Med 2011;171:1369-1370.
45. Bahr JM, Nakai M, Rivera A, et al. Dietary soy protein and isoflavones: Minimal beneficial effects on bone and no effect on the reproductive tract of sexually mature ovariectomized Sprague-Dawley rats. Menopause 2005;12:165-173.
46. Fanti P, Monier-Faugere MC, Geng Z, et al. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 1998;8:274-281.
47. Gallo D, Zannoni GF, Apollonio P, et al. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: Effects on bone, uterus, and lipid profile. Menopause 2005;12:589-600.
48. Hertrampf T, Schleipen B, Offermanns C, Velders M, Laudenbach U, Diel P. Comparison of the bone protective effects of an isoflavone-rich diet with dietary and subcutaneous administrations of genistein in ovariectomized rats. Toxicol Lett 2009;184:198-203.
49. Nakai M, Cook L, Pyter LM, et al. Dietary soy protein and isoflavones have no significant effect on bone and a potentially negative effect on the uterus of sexually mature intact Sprague-Dawley female rats. Menopause 2005;12:291-298.
50. Sehmisch S, Erren M, Kolios L, et al. Effects of isoflavones equol and genistein on bone quality in a rat osteopenia model. Phytother Res 2010;24:S168-S174.
51. Lotinun S, Westerlind KC, Turner RT. Tissue-selective effects of continuous release of 2-hydroxyestrone and 16>-hydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats. J Endocrinol 2001;170:165-174.
52. Westerlind KC, Gibson KJ, Malone P, Evans GL, Turner RT. Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats. J Bone Miner Res 1998;13:1023-1031.
53. Maran A, Shogren K, Zhang M, et al. Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-> on regulation of gene expression by tibolone. Bone 2006;39:523-529.
54. Notelovitz M. Postmenopausal tibolone therapy: Biologic principles and applied clinical practice. MedGenMed 2007;9:2.
55. Turner RT, Colvard DS, Spelsberg TC. Estrogen inhibition of periosteal bone formation in rat long bones: Down-regulation of gene expression for bone matrix proteins. Endocrinology 1990;127:1346-1351.
56. Turner RT, Evans GL, Wakley GK. Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: Inhibition of indices of formation and resorption. J Bone Miner Res 1993;8:359-366.
57. Campen CA, Jordan VC, Gorski J. Opposing biological actions of antiestrogens in vitro and in vivo: Induction of progesterone receptor in the rat and mouse uterus. Endocrinology 1985;116:2327-2336.
58. Lyman SD, Jordan VC. Metabolism of tamoxifen and its uterotrophic activity. Biochem Pharmacol 1985;34:2787-2794.
59. Urist MR, Budy AM, McLean FC. Species differences in the reaction of the mammalian skeleton to estrogens. Proc Soc Exp Biol Med 1948;68: 324-326.
60. Urist MR, Budy AM, McLean FC. Endosteal-bone formation in estrogentreated mice. J Bone Joint Surg Am 1950;32A:143-162.
61. Kaludjerovic J, Ward WE. Neonatal administration of isoflavones attenuates deterioration of bone tissue in female but not male mice. J Nutr 2010;140:766-772.
62. Ward WE, Fonseca D. Soy isoflavones and fatty acids: Effects on bone tissue postovariectomy in mice. Mol Nutr Food Res 2007;51:824-831.
63. Turner RT, Maran A, Lotinun S, et al. Animal models for osteoporosis. Rev Endocr Metab Disord 2001;2:117-127.
64. Jackson MA, Iwaniec UT, Turner RT, Wronski TJ, Kalra SP. Effects of increased hypothalamic leptin gene expression on ovariectomy-induced bone loss in rats. Peptides 2011;32:1575-1580.
65. Turner RT, Riggs BL, Spelsberg TC. Skeletal effects of estrogen. Endocr Rev 1994;15:275-300.
66. Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A. Bioavailability of phyto-oestrogens. Br J Nutr 2003;89(Suppl 1): S45-S58.
67. de Lemos ML. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann Pharmacother 2001;35:1118-1121.
68. Henley DV, Korach KS. Physiological effects and mechanisms of action of endocrine disrupting chemicals that alter estrogen signaling. Hormones (Athens) 2010;9:191-205.
69. Jefferson WN, Williams CJ. Circulating levels of genistein in the neonate, apart from dose and route, predict future adverse female reproductive outcomes. Reprod Toxicol 2011;31:272-279.